Pricing Log in Create free account

Structure Therapeutics Inc. Sponsored ADR (GPCR) vs Immunocore Holdings PLC Sponsored ADR (IMCR)

Structure Therapeutics Inc. Sponsored ADR and Immunocore Holdings PLC Sponsored ADR are both Biotechnology companies. Structure Therapeutics Inc. Sponsored ADR and Immunocore Holdings PLC Sponsored ADR are of similar size ($1.6B and $1.5B). Structure Therapeutics Inc. Sponsored ADR has the higher net margin (0.00% vs −4.20%) and the lower return on invested capital (−1,371.8% vs 0.00%). Across the 14 metrics below, Structure Therapeutics Inc. Sponsored ADR leads on 7 and Immunocore Holdings PLC Sponsored ADR on 7.

Valuation

Metric GPCR IMCR Biotechnology median
P/E n/m n/m 8.50
P/S n/m 3.48 9.71
P/B 1.12 3.57 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 2.46 9.21
Earnings yield (14.35%) (1.22%) (33.15%)
Free cash flow yield (14.75%) (2.75%) (25.50%)

Profitability

Metric GPCR IMCR Biotechnology median
Gross margin 0.00% 98.90% 65.16%
Operating margin 0.00% (5.24%) 0.00%
Net margin 0.00% (4.20%) 0.00%
Free cash flow margin 0.00% (9.55%) 0.00%
Return on equity (20.21%) (4.47%) (56.36%)
Return on assets (19.17%) (1.64%) (48.04%)
Return on invested capital (1,371.78%) 0.00% 0.00%

Growth

Metric GPCR IMCR Biotechnology median
Revenue growth (TTM) — 20.95% 6.02%
EPS growth (last fiscal year) (2.47%) 30.39% 30.26%
Revenue growth, 5-year CAGR — 59.57% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GPCR IMCR Biotechnology median
Debt to equity 0.00 0.94 0.00
Current ratio 20.75 4.47 4.72
Net debt to EBITDA 8.27 11.19 0.96

Dividend

Metric GPCR IMCR Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric GPCR IMCR Biotechnology median
Market cap 1.58b 1.52b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack